OTRK $0.48 1.957%
1383.HK $0.17 0.5988%
CHPT $8.26 -3.7296%
0LC3.L $27.41 2.1618%
ALGBE.PA $2.76 35.6265%
HTD $20.08 -0.0747%
1348.HK $0.08 -3.75%
0P0000SHY7.L $10 578.00 0.8283%
SNTI $0.95 -4.1208%
CNR $24.66 0%
REET $22.78 -1.1285%
2039.HK $5.13 -1.3461%
0572.HK $1.17 -10%
AZEV4.SA $1.45 0%
VIAC $29.58 0%
0202.HK $0.17 2.454%
FLLV $46.82 -0.4677%
AMBP3.SA $21.01 -2.551%
JHMM $46.25 -0.5162%
3700.HK $0.95 -1.0417%
NMZ $10.46 0.2926%
6288.HK $18.10 0%
IGSB $50.58 -0.2337%
0K6O.L $3.92 -3.2404%
MGIC $14.23 0%
CRZNU $10.22 0%
INKA $10.42 0%
PCEU.PA $26.56 0.492%
FRGE.L $35.27 -1.1214%
1427.HK $0.23 -1.2875%
CMCL.L $1 070.00 -2.2831%
BILL $94.14 -5.4059%
PTON $6.81 -0.7289%
URU.L $150.00 4.8951%
PPHPU $10.45 2.7532%
PETZ3.SA $7.20 -2.3066%
LPLA $188.13 0.0904%
0EDE.L $163.19 0.2745%
AAU.L $2.63 -0.9434%
TYM.L $0.15 -3.3333%
UJPY $25.47 0%
PEAB4.SA $61.95 6.9948%
CSCW $1.08 0%
MDV $13.00 -3.2641%
8441.HK $1.30 0%
JLL $137.12 0.2339%
JEO.L $843.00 0%
ABEV $2.90 -0.1724%
JT $1.16 -5.6911%
SK6U.SI $0.94 0.5348%
SHCR $1.46 -1.0204%
SSTY.L $26.50 0%
VRTS $170.22 -0.6189%
GCT $5.18 -1.145%
S29.SI $0.20 3.6649%
HEWU $26.01 -0.2179%
BITO $15.22 -1.8698%
3369.HK $1.55 1.9737%
SVRE $1.47 -2%
XGSG.L $2 414.75 -0.2685%
EQH-PC $16.30 -0.8516%
0W19.L $61.40 0.9767%
NBHC $29.01 0.1727%
KNB.L $2.93 2.6316%
VOXX $12.13 0.4971%
SOFO $0.83 2.2167%
GNSS $2.44 3.8298%
DFFN $4.06 3.4052%
PSA-PF $24.42 -0.1635%
GOVD.L $6.63 0.905081%
CSU $33.54 0%
IDA $109.13 0.055%
LOOP.L $2.70 0%
EDVD.L $13.28 -0.7288%
0528.HK $1.41 0%
8166.HK $0.05 0%
EVFM $0.02 8.5526%
SBFM $0.73 -18.5222%
FMIVW $0.11 0%
RVPH $7.40 -6.5657%
OCG $0.48 -1.0208%
EXPO $86.10 -0.3933%
BGCG.L $227.00 -1.5184%
AZYO $2.28 0%
8237.HK $0.02 0%
0RDI.L $555.48 1.4242%
0398.HK $4.62 -0.6452%
FR.PA $17.63 1.6138%
FDR.MC $16.84 -1.1737%
VTSAX $99.55 -0.2205%
PET.L $1.40 0%
0142.HK $2.95 -0.6734%
1269.HK $0.06 1.8518%
ADM $74.79 -0.1535%
AAF.L $115.10 3.0439%
BEC.SI $1.65 0%
AMRX $1.87 -0.5319%
CIBR.L $25.99 -0.4406%
SLS.L $732.00 0%
TUI.L $510.80 -2.9635%
Eng
Логотип
Eng
Лого

ValiRx plc VAL.L

$10.00

На 18:02, 12 мая 2023

Ранг: 3

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    9976200.00000000

  • week52high

    31.00

  • week52low

    8.68

  • Revenue

    0

  • P/E TTM

    -410

  • Beta

    1.48320600

  • EPS

    -0.03000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    05 июн 2023 г. в 10:59

Описание компании

ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company's lead drug candidates include VAL201, a small molecule that has completed Phase I/II trials for the treatment of prostate cancer and other hormone associated solid tumours comprising breast and ovarian cancer; and VAL401, a reformulation of anti-psychotic drug risperidone, which has completed Phase II clinical trial for the treatment of non-small cell lung cancer. Its drug candidates also comprise VAL301, a peptide ingredient that in pre-clinical development for the treatment of women with endometriosis; and BC201, a combination of the peptide ingredient of VAL201/VAL301 with complementary active components for the treatment for patients suffering severe symptoms of Covid-19. ValiRx plc was incorporated in 2000 and is based in Hatfield, the United Kingdom.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек